(Q33542798)

27 July 2017

1 reference

title

Growth hormone deficiency and cardiovascular risk (English)

1 reference

growth hormone deficiency

27 July 2017

1 reference

1 reference

Hew FL

1

1 reference

27 July 2017

O'Neal D

2

1 reference

27 July 2017

Kamarudin N

3

1 reference

27 July 2017

Alford FP

4

1 reference

27 July 2017

Best JD

5

1 reference

27 July 2017

1 July 1998

1 reference

Bailliere's clinical endocrinology and metabolism

27 July 2017

1 reference

27 July 2017

12

1 reference

27 July 2017

199-216

1 reference

27 July 2017

2

1 reference

Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Post-heparin plasma lipase activity in hypopituitary adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Metabolic implications of body fat distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Serum lipid levels in growth hormone-deficient men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Clinical aspects of growth hormone deficiency in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Cardiovascular and renal effects of growth hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

The growth hormone deficiency syndrome in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Greater effect of diabetes on LDL size in women than in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Growth hormone-deficient adults are insulin-resistant.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Role of lipids and lipoprotein fractions in atherogenesis: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Long-term follow-up of hypopituitary patients treated with human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Experience with human growth hormone in Great Britain: the report of the MRC Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Low dose continuously infused growth hormone results in increased lipoprotein(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Growth hormone and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Premature mortality due to cardiovascular disease in hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Cardiovascular risk factors in adult patients with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Growth hormone and the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

The mysteries of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2898%2980018-9

7 January 2021

10.1016/S0950-351X(98)80018-9

Identifiers

DOI

1 reference

27 July 2017

1 reference